The transcription factor Blimp-1 has emerged as a regulator of cell fate in embryonic (germ cell) and adult (B-and T-cell immune effector and epithelial) lineages. It has also been proposed to act as a tumor suppressor in B-cell malignancy. Here, we present a novel in vivo system enabling the targeted genetic manipulation of cells expressing Prdm1, the gene encoding Blimp-1. We created bacterial artificial chromosome-transgenic mice expressing the avian leukosis virus (ALV) receptor TVB, fused to monomeric red fluorescent protein, under regulation by Prdm1 transcriptional elements, and we achieved transduction of TVB-expressing lymphocytes by ALV vectors bearing a subgroup B envelope. The system presented here incorporates a number of innovations. First, it is the first mammalian transgenic system that employs the ALV receptor TVB, thus expanding the flexibility and scope of ALV-mediated gene delivery. Second, it represents the first ALV-based system that allows gene transfer and expression into in vivo-activated mature lymphocytes, a cell type that has traditionally presented formidable challenges to efficient retroviral transduction. Third, Prdm1:TVB-mRFP transgenic animals could provide an invaluable tool for exploring the diverse roles of Blimp-1 in lineage commitment, immune regulation, and tumorigenesis.The development of in vivo models that enable the genetic manipulation of cells in the earliest stages of commitment to a specific lineage could provide a powerful means for studying normal development as well as recreating the clonal origins of cancer experimentally.Tumors derived from mature, antigen-experienced lymphocytes often express Prdm1, the gene encoding the transcription factor Blimp-1. Blimp-1 is a zinc finger-containing transcriptional regulator with key roles in cell fate specification in diverse embryonic and adult lineages (29). During mouse embryogenesis, Blimp-1 commits primordial cells to a germ cell fate (32). In the adult, Blimp-1 is indispensable for the maturation and/or function of important subsets of immune effector cells as well as some epithelial cells, including subsets with stem cell properties (18, 28).Blimp-1 was initially identified as the master regulator of plasma cell differentiation (2,19,22,26,27,37,(40)(41)(42)45). Conditional deletion of Prdm1 in the B-cell lineage results in abrogation of plasma cell development (41). Mature plasma cells, resident in the bone marrow, remain dependent on continued expression of Prdm1 (42). Malignant plasma cells in multiple myeloma, as well as malignant B cells in some cases of mature B-cell lymphomas, also express Prdm1 (6). In other cases, inactivation of Prdm1 by mutation, deletion, or transcriptional silencing has been proposed to prevent differentiation of malignant B cells, thus attributing a tumor suppressor role to Prdm1 in diffuse large B-cell lymphoma (36, 44). More recently, Blimp-1 has been credited with critical functions in the maturation and homeostasis of effector T cells (12,23,(29)(30)(31)38), including regulatory T ...